These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 15451458)
1. Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells. Eliopoulos N; Lejeune L; Martineau D; Galipeau J Mol Ther; 2004 Oct; 10(4):741-8. PubMed ID: 15451458 [TBL] [Abstract][Full Text] [Related]
2. A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice. Eliopoulos N; Al-Khaldi A; Crosato M; Lachapelle K; Galipeau J Gene Ther; 2003 Mar; 10(6):478-89. PubMed ID: 12621452 [TBL] [Abstract][Full Text] [Related]
3. Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure. Eliopoulos N; Gagnon RF; Francois M; Galipeau J J Am Soc Nephrol; 2006 Jun; 17(6):1576-84. PubMed ID: 16672321 [TBL] [Abstract][Full Text] [Related]
4. Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD/SCID mice. Daga A; Muraglia A; Quarto R; Cancedda R; Corte G Gene Ther; 2002 Jul; 9(14):915-21. PubMed ID: 12085239 [TBL] [Abstract][Full Text] [Related]
5. Neo-organoid of marrow mesenchymal stromal cells secreting interleukin-12 for breast cancer therapy. Eliopoulos N; Francois M; Boivin MN; Martineau D; Galipeau J Cancer Res; 2008 Jun; 68(12):4810-8. PubMed ID: 18559528 [TBL] [Abstract][Full Text] [Related]
6. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells. Eliopoulos N; Al-Khaldi A; Beauséjour CM; Momparler RL; Momparler LF; Galipeau J Gene Ther; 2002 Apr; 9(7):452-62. PubMed ID: 11938460 [TBL] [Abstract][Full Text] [Related]
8. Organoids direct systemic expression of erythropoietin in mice. Descamps V; Blumenfeld N; Perricaudet M; Beuzard Y; Kremer EJ Gene Ther; 1995 Aug; 2(6):411-7. PubMed ID: 7584116 [TBL] [Abstract][Full Text] [Related]
9. Cell-based gene therapy modifies matrix remodeling after a myocardial infarction in tissue inhibitor of matrix metalloproteinase-3-deficient mice. Angoulvant D; Fazel S; Weisel RD; Lai TY; Fedak PW; Chen L; Rafati S; Seneviratne CK; Degousee N; Li RK J Thorac Cardiovasc Surg; 2009 Feb; 137(2):471-80. PubMed ID: 19185172 [TBL] [Abstract][Full Text] [Related]
10. Local ex vivo gene therapy with bone marrow stromal cells expressing human BMP4 promotes endosteal bone formation in mice. Zhang XS; Linkhart TA; Chen ST; Peng H; Wergedal JE; Guttierez GG; Sheng MH; Lau KH; Baylink DJ J Gene Med; 2004 Jan; 6(1):4-15. PubMed ID: 14716672 [TBL] [Abstract][Full Text] [Related]
11. Transduction of human EPO into human bone marrow mesenchymal stromal cells synergistically enhances cell-protective and migratory effects. Kim MH; Cho GW; Huh YM; Kim SH Mol Biol (Mosk); 2010; 44(4):656-63. PubMed ID: 20873225 [TBL] [Abstract][Full Text] [Related]
12. Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts. Régulier E; Schneider BL; Déglon N; Beuzard Y; Aebischer P Gene Ther; 1998 Aug; 5(8):1014-22. PubMed ID: 10326023 [TBL] [Abstract][Full Text] [Related]
13. [Heterotopic osteogenesis of autogenous marrow stromal cells on ceramic bovine bone/ hydrogel scaffold]. He D; Jin Y; Luo K; Li S Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Feb; 20(2):116-20. PubMed ID: 16529318 [TBL] [Abstract][Full Text] [Related]
14. Co-transplantation of bone marrow stromal cells transduced with IL-7 gene enhances immune reconstitution after allogeneic bone marrow transplantation in mice. Li A; Zhang Q; Jiang J; Yuan G; Feng Y; Hao J; Li C; Gao X; Wang G; Xie S Gene Ther; 2006 Aug; 13(15):1178-87. PubMed ID: 16598299 [TBL] [Abstract][Full Text] [Related]
15. Antitumor treatment using interleukin- 12-secreting marrow stromal cells in an invasive glioma model. Hong X; Miller C; Savant-Bhonsale S; Kalkanis SN Neurosurgery; 2009 Jun; 64(6):1139-46; discussion 1146-7. PubMed ID: 19487894 [TBL] [Abstract][Full Text] [Related]
17. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Zhao Z; Zhao M; Xiao G; Franceschi RT Mol Ther; 2005 Aug; 12(2):247-53. PubMed ID: 16043096 [TBL] [Abstract][Full Text] [Related]
18. [Effect of injectable fibrin sealant compounded with bone morphogenetic protein on proliferation and differentiation of marrow stromal cells towards osteoblasts in rabbits]. Cui G; Li J; Lei W Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Jan; 21(1):70-5. PubMed ID: 17305009 [TBL] [Abstract][Full Text] [Related]
19. BDNF-expressing marrow stromal cells support extensive axonal growth at sites of spinal cord injury. Lu P; Jones LL; Tuszynski MH Exp Neurol; 2005 Feb; 191(2):344-60. PubMed ID: 15649491 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Rose RA; Jiang H; Wang X; Helke S; Tsoporis JN; Gong N; Keating SC; Parker TG; Backx PH; Keating A Stem Cells; 2008 Nov; 26(11):2884-92. PubMed ID: 18687994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]